scispace - formally typeset
X

Xi Chen

Researcher at Peking Union Medical College Hospital

Publications -  45
Citations -  5311

Xi Chen is an academic researcher from Peking Union Medical College Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 34 publications receiving 3889 citations. Previous affiliations of Xi Chen include Simon Fraser University & Zhengzhou University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Enhanced recovery after surgery for hip and knee arthroplasty: a systematic review and meta-analysis.

TL;DR: The meta-analysis showed that ERAS significantly reduces LOS and incidence of complications in patients who have had THA or TKA, but ERAS does not appear to significantly impact 30-day readmission rates.
Journal ArticleDOI

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients.

TL;DR: Exo-PD-L1, but not sPD- l1, was correlated with NSCLC disease progression, including tumor size, lymph node status, metastasis and TNM stage, however, Exo- PD-l1 was not associated with PD-L 1 IHC status.
Journal ArticleDOI

Epidemiological and Clinical Characteristics of COVID-19 in Children: A Systematic Review and Meta-Analysis.

TL;DR: In conclusion, the transmissibility of pediatric COVID-19 should be not ignored because of the relatively long incubation period, shedding duration, and mild clinical syndromes.
Journal ArticleDOI

The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts.

TL;DR: In this paper, the molecular and cellular mechanisms of inflammatory tissue priming are defined and the checkpoints between remission and persistence remain unknown. But, they suggest possibilities for therapeutic intervention abrogating tissue pre-priming without immunosuppression.